TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT04000230

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: TCIT
Description: TCIT consists of the following:~* CDI Teach Session: Teachers will participate in two training workshops in Child-Directed Interaction (CDI) skills. Specifically, teachers will learn to use positive attention skills and active ignoring.~* CDI Coaching: Teachers will receive 90 minutes of CDI coaching in the classroom once or twice weekly for 6 total coaching sessions over a period of 4-6 weeks. The coach will observe the class and coach the teacher live using a microphone and bug-in-the-ear device.~* TDI Teach Session: Teachers will complete two training workshops in Teacher Directed Interaction (TDI) skills, which focus on increasing compliance and reducing disruptive behavior. Teachers will learn to present developmentally appropriate, direct, and clear instructions and consistent positive and negative consequences.~* TDI Coaching: Teachers will receive six 90-minute TDI coaching sessions once or twice weekly for 4-6 weeks.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TCIT
Description: TCIT consists of the following:~* CDI Teach Session: Teachers will participate in two training workshops in Child-Directed Interaction (CDI) skills. Specifically, teachers will learn to use positive attention skills and active ignoring.~* CDI Coaching: Teachers will receive 90 minutes of CDI coaching in the classroom once or twice weekly for 6 total coaching sessions over a period of 4-6 weeks. The coach will observe the class and coach the teacher live using a microphone and bug-in-the-ear device.~* TDI Teach Session: Teachers will complete two training workshops in Teacher Directed Interaction (TDI) skills, which focus on increasing compliance and reducing disruptive behavior. Teachers will learn to present developmentally appropriate, direct, and clear instructions and consistent positive and negative consequences.~* TDI Coaching: Teachers will receive six 90-minute TDI coaching sessions once or twice weekly for 4-6 weeks.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Booster
Description: Teachers in the Intervention group will receive additional booster sessions during the second half of the school year. Booster sessions consist of coaching teachers in CDI and TDI skills. Teachers receive 4-8 booster sessions.
Study: NCT04593849

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Ru-Yih-Jin- Huang-Saan(RYJHS), Wan-Yin-Gao-Jia-Jean-Wey(WYGJJW), placebo ( topical agent without therapeutic effects)
Description: We conduct a clinical trial using topical herbal medicine, including Ru-Yih-Jin- Huang-Saan(RYJHS) and Wan-Yin-Gao-Jia-Jean-Wey (WYGJJW) in treating post fracture pain and tissue swell. 24 eligible participants diagnosed of upper limb fracture with soft tissue injury grading of C1, C0 from Tscherne classification transferred from Orthopedic outpatient clinic and inpatient will be enrolled and randomly allocated to 4 groups, including experimental group A (RYJHS group), group B (WYGJJW group), placebo group( topical agent without therapeutic effects), and control group (only oral analgesics group), with 6 participants in each group.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ru-Yih-Jin- Huang-Saan(RYJHS), Wan-Yin-Gao-Jia-Jean-Wey(WYGJJW), placebo ( topical agent without therapeutic effects)
Description: We conduct a clinical trial using topical herbal medicine, including Ru-Yih-Jin- Huang-Saan(RYJHS) and Wan-Yin-Gao-Jia-Jean-Wey (WYGJJW) in treating post fracture pain and tissue swell. 24 eligible participants diagnosed of upper limb fracture with soft tissue injury grading of C1, C0 from Tscherne classification transferred from Orthopedic outpatient clinic and inpatient will be enrolled and randomly allocated to 4 groups, including experimental group A (RYJHS group), group B (WYGJJW group), placebo group( topical agent without therapeutic effects), and control group (only oral analgesics group), with 6 participants in each group.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Ru-Yih-Jin- Huang-Saan(RYJHS), Wan-Yin-Gao-Jia-Jean-Wey(WYGJJW), placebo ( topical agent without therapeutic effects)
Description: We conduct a clinical trial using topical herbal medicine, including Ru-Yih-Jin- Huang-Saan(RYJHS) and Wan-Yin-Gao-Jia-Jean-Wey (WYGJJW) in treating post fracture pain and tissue swell. 24 eligible participants diagnosed of upper limb fracture with soft tissue injury grading of C1, C0 from Tscherne classification transferred from Orthopedic outpatient clinic and inpatient will be enrolled and randomly allocated to 4 groups, including experimental group A (RYJHS group), group B (WYGJJW group), placebo group( topical agent without therapeutic effects), and control group (only oral analgesics group), with 6 participants in each group.
Study: NCT03904615

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Whey Protein
Description: 30 g of whey protein in flavored water, twice daily, during hospitalization and for 30 days post-discharge

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Collagen Protein
Description: 30 g of collagen protein in flavored water, twice daily, during hospitalization and for 30 days post-discharge

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 30 g of maltodextrin in flavored water, twice daily, during hospitalization and for 30 days post-discharge
Study: NCT01450800

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants randomized to placebo will be instructed to take placebo one tablet by mouth daily starting on postoperative day 1 for up to 7 days during catheterization
Study: NCT04598958

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: IMPROVE
Description: Health system interventions that include: (1) Multidisciplinary integrated management teams to coordinate patient-focused and outcome-oriented PMTCT and MCH services; (2) Enhanced Positive Health, Dignity, and Prevention (PHDP)-focused counseling and skills-building training and job aids; and (3) Increased early community-based counseling and support for first (antenatal care clinic) ANC attendees
Study: NCT00127166

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Montelukast sodium
Description: Montelukast 5 mg chewable tablet once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Montelukast sodium
Description: Montelukast 5 mg chewable tablet once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salmeterol xinafoate
Description: Salmeterol 50 mcg dry powder per actuation inhaled twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salmeterol xinafoate
Description: Salmeterol 50 mcg dry powder per actuation inhaled twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Description: Fluticasone (50 mcg per actuation) 100 mcg inhaled twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate
Description: Fluticasone (50 mcg per actuation) 100 mcg inhaled twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Montelukast matching placebo
Description: Matching placebo to montelukast oral tablet administered once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Montelukast matching placebo
Description: Matching placebo to montelukast oral tablet administered once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salmeterol matching placebo
Description: Matching placebo to salmeterol dry powder for inhalation administered twice daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salmeterol matching placebo
Description: Matching placebo to salmeterol dry powder for inhalation administered twice daily
Study: NCT03926416

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CodaVax-H1N1
Description: Live-attenuated vaccine against influenza A H1N1, A/California/07/2009

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CodaVax-H1N1
Description: Live-attenuated vaccine against influenza A H1N1, A/California/07/2009

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: CodaVax-H1N1
Description: Live-attenuated vaccine against influenza A H1N1, A/California/07/2009

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Fluzone quadrivalent
Description: Fluzone® (QuadriFlu - TIV), inactivated, quadrivalent influenza vaccine

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Fluzone quadrivalent
Description: Fluzone® (QuadriFlu - TIV), inactivated, quadrivalent influenza vaccine
Study: NCT01348958

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iDXA knee software
Description: Following surgery, subjects who have undergone knee arthroplasty will have the knee that has undergone arthroplasty (post-operative) scanned at least 8 weeks after surgery.~During one visit, each subject will have the post-operative knee scanned 1 time using Lunar orthopedic application, and 3 times with the subject repositioned between scans using the Lunar orthopedic knee application (total of 4 scans). Lunar iDXA measurement procedures will be done
Study: NCT01591824

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Resonant oscillation
Description: Resonant sustained oscillations are applied in the following areas~* general column.~* lumbar muscles, and paraspinal muscles,~* sacral decompression oscillatory~* Opening by lateral vertebral lumbar rhythmic swing.~* Balancing and pelvic decompression~* Swing-lumbar vertebral rotation.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: column exercise group
Description: * paraspinal muscle stretching exercises~* postural correction~* mobilization exercises thoracic and lumbar~* Motor control exercises
Study: NCT01460030

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cinacalcet HCl
Description: Oral administration
Study: NCT04305470

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gleolan (Aminolevulinic Acid Hydrochloride/ALA/ALA-HCI)
Description: One time oral dose on day of surgery (20 mg/kg bodyweight)
Study: NCT03116022

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Distal estriol
Description: Women using drug 1 mg / 1g at the distal third of the vagina every other night for 12 weeks

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Vaginal Gel
Description: Women using a base water gel lubricant during intercourse
Study: NCT01787747

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AVP-786 Dose 1
Study: NCT04429113

Intervention type: DEVICE
Intervention: Maxillary expansion with conventional Quad Helix bonded on molars.
Description: Maxillary expansion with conventional Quad Helix bonded on molars

Intervention type: DEVICE
Intervention: Maxillary expansion with conventional Quad Helix bonded on molars.
Description: Maxillary expansion with conventional Quad Helix bonded on molars
Study: NCT00310492

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: subcutaneous immunotherapy
Description: Updosing by 16 injections to 100,000 SQ-U

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: subcutaneous immunotherapy
Description: Updosing by 16 injections to 100,000 SQ-U
Study: NCT02399891

Intervention type: OTHER
Intervention: Quality Assurance Implementation

Intervention type: OTHER
Intervention: Standard of Care
Study: NCT03727945

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: abdominopelvic exercise and posture
Description: n=21 women received supervised abdominopelvic exercise with previous postural correction. During 12 sessions a specialized physiotherapist supervised to realization of progressive abdominopelvic exercises, previous explain postural correction pelvis, cervical and dorsal zone.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: abdominopelvic exercise
Description: n=21 women received supervised abdominopelvic exercise. During 12 sessions a specialized physiotherapist supervised to realization of progressive abdominopelvic exercises.
Study: NCT05484791

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Lumbar Rotational Spinal Mobilization Technique
Description: Patients included in the study underwent the lumbar rotational spinal mobilization(LRSM) technique during two sessions per week. The LRSM technique is applied while patients are lying on their side. The uppermost hip and knee are placed in 90 degree flexion, this is to assist rotational stress, and the lower leg is placed in extension. The lower shoulder is strongly pulled; thus, the upper shoulder is positioned toward the posterior and the pelvis moves anteriorly. The clinician stands in front of the patient. They stabilize the upper shoulder with one hand, and place the palm of the other hand behind the hard part of the ilium wing, with forearm horizontal and fingers turned toward the clinician. A rotational force is applied with pressure in the horizontal direction by pulling the hand on the ilium toward the clinician. In this position, 30 slow repeated movements are performed. The same practice is performed on both sides
Study: NCT03945916

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dark chocolate
Description: 180 g/d dark chocolate for 15 days followed by exercise testing

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo: 180 g/d imitation dark chocolate for 15 days followed by exercise testing
Study: NCT02263768

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Oral clinical conditions
Description: Caries incidence assessment dental anxiety assessment oral health related quality of life assessment time and costs assessment
Study: NCT01787747

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AVP-786 Dose 2

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AVP-786 Dose 1/Q Dose 1

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AVP-786 Dose 1/Q Dose 2

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AVP-786 Dose 2/Q Dose 2

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AVP-923

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AVP-923

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AVP-923
Study: NCT06696196

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: smart watches(wearable devices)
Description: Participants will be asked to wear two smart watches simultaneously. The first smart watch is a dedicated prototype for validating algorithm developed by MediaTek. The second smart watch is Basis Peak. These watches are going to acquire PPG, body movements, skin temperature, and skin conductance.
Study: NCT02707016

Intervention type: OTHER
Group type: OTHER
Intervention: Sevoflurane 8%
Description: Sevoflurane 8% (high dose) during anesthesia induction

Intervention type: OTHER
Group type: OTHER
Intervention: Sevoflurane 5%
Description: Sevoflurane 5% (low dose) during anesthesia induction
Study: NCT06400225

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan
Study: NCT02754544

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Direct Electrocortical Stimulation
Description: Undergo direct electrocortical stimulation
Study: NCT06400225

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Echocardiography
Description: Undergo ECHO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radionuclide Imaging
Description: Undergo nuclear study

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ulixertinib
Description: Given PO
Study: NCT02515487

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Brain Fitness Program (BFP)
Description: The program is designed to improve processing speed of auditory information and attention. The BFP is comprised of six computerized subtests that continuously adjust in the level of difficulty to maintain an 85% correct response rate. The subtest exercises include discrimination of confusable syllables, recognition of sequences of syllables, matching pairs of confusable syllables, reconstruction of sequences of verbal instructions and identification of details in a verbally presented story. Participants will participate in 40 one-hour training sessions over a 12 week period to complete all cognitive remediation training sessions. Since this intervention is presented both visually and verbally, noise cancelling headphones will be provided to the participants.
Study: NCT01057173

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Implantation
Description: Retrograde trans-femoral or trans-subclavian aortic valve implantation with the Medtronic CoreValve System(TM) bio-prosthesis (third generation system, 18 Fr, CE mark approved)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Surgical Aortic Valve Replacement
Description: Conventional surgical aortic valve replacement with a bio-prosthesis using normothermic cardiopulmonary bypass and cold blood cardioplegia cardiac arrest
Study: NCT03581162

Intervention type: DIAGNOSTIC_TEST
Intervention: Carotid Ultrasound and venous blood sampling
Description: Carotid ultrasound and blood sampling

Intervention type: DIAGNOSTIC_TEST
Intervention: Carotid Ultrasound and venous blood sampling
Description: Carotid ultrasound and blood sampling
Study: NCT02079233

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cross-Linked Polyelectrolyte (CLP)
Description: CLP was administered orally, in capsules, for 7 consecutive days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cross-Linked Polyelectrolyte (CLP)
Description: CLP was administered orally, in capsules, for 7 consecutive days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cross-Linked Polyelectrolyte (CLP)
Description: CLP was administered orally, in capsules, for 7 consecutive days.
Study: NCT02754544

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electrocorticography
Description: Undergo electrocorticography
Study: NCT02079233

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cross-Linked Polyelectrolyte (CLP)
Description: CLP was administered orally, in capsules, for 7 consecutive days.
Study: NCT02684331

Intervention type: OTHER
Intervention: Cardiac Magnetic Resonance Imaging (CMR)
Description: An extensive explorative CMR protocol, including time/volume curves of LV and LA, rest and stress perfusion (with Adenosin) and time/volume curve of LA after chronotropic stress with Glycopyrrolate, further flow measurements and T1 mapping.

Intervention type: OTHER
Intervention: Echocardiography
Description: Standard measurements and strain.

Intervention type: OTHER
Intervention: Bood samples
Description: HbA1c, Glucose, Hgb, Creatinin, Sodium, Potassium, Total cholesterol, LDL cholesterol, HDL cholesterol, Free fatty acids, ALAT, Urinary albumin, NT-proBNP, ANP, suPAR, Copeptin, Proendothelin, proCNP, Soluble ST2, Galectin-3
Study: NCT03944109

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-1209
Description: Pharmaceutical form: lyophilized formulation~Route of administration: subcutaneous

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Pharmaceutical form: lyophilized formulation~Route of administration: subcutaneous
Study: NCT01931345

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing Counseling
Description: Counseling developed by the research team based on a motivational interviewing approach

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard counseling
Description: Counseling based on Quebec guidelines for rapid HIV testing
Study: NCT02428348

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interview about prototype EEG-cap
Study: NCT03522025

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Unicompartmental Knee Arthroplasty (UKA)
Description: Unicompartmental Knee Arthroplasty (UKA) is a less invasive treatment option compared to Total Knee Arthroplasty (TKA) for patients with primary anteromedial knee osteoarthritis.
Study: NCT01872507

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Biofeedback training
Description: usual treatment +12 biofeedback training
Study: NCT01787747

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AVP-923

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AVP-923
Study: NCT03920280

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: LID015385 contact lenses
Description: Investigational silicone hydrogel contact lenses

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Comfilcon A soft contact lenses
Description: Commercially available silicone hydrogel contact lenses

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CLEAR CARE
Description: Hydrogen peroxide-based cleaning and disinfecting system

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CLEAR CARE
Description: Hydrogen peroxide-based cleaning and disinfecting system
Study: NCT02103101

Intervention type: OTHER
Group type: OTHER
Intervention: Measurement of Plasma Concentrations of NOACs
Description: Plasma concentrations of dabigatran, rivaroxaban or apixaban will be measured using High Performance Liquid Chromatography (HPLC) coupled with tandem mass spectrometry (MS/MS). Blood samples will be taken in an EDTA tube and rapidly centrifugated. Plasma will be aliquoted and frozen at minus 80 degrees Celsius for later analysis.

Intervention type: GENETIC
Group type: OTHER
Intervention: Identification of ABCB1 polymorphisms coding for P-gp
Description: To investigate the existence of a relation between polymorphisms of ABCB1 and plasma concentrations of new oral anticoagulants, the SNaPshot® Multiplex System will be used enabling multiplexing of SNPs (single nucleotide polymorphisms) of the ABCB1 gene (namely rs4148738, rs2235046, rs1128503, rs10276036, rs1202169, rs1202168, rs1202167).
Study: NCT03252990

Intervention type: DIAGNOSTIC_TEST
Intervention: PET-MRI
Description: Additional 18F-choline PET-MRI examination

Intervention type: DIAGNOSTIC_TEST
Intervention: PET-MRI
Description: Additional 18F-choline PET-MRI examination

Intervention type: PROCEDURE
Intervention: Optical Coherence Tomography
Description: Additional optical coherence tomography (OCT) examination (during the already planned routine PCI procedure)
Study: NCT02359864

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 5 daily fractions of 2 Gy
Description: Whole Brain Irradiation to treat Alzheimer's Disease

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 10 daily fractions of 2 Gy
Description: Whole Brain Irradiation to treat Alzheimer's Disease